FDA Approves First Treatment for Group of Progressive Interstitial Lung …
The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive ...
Review the latest updates on ILD diagnosis ... - CHEST Daily News
Sep 26, 2023 · Interstitial lung disease (ILD) encompasses a broad and variable group of diseases. They often have common symptoms and physical findings but can have different treatments and outcomes, making management challenging for both patients and clinicians. Debbie Levine, MD, MS, FCCP.
Updates in interstitial lung disease: Current facets of anti …
While ushering in an era of medical treatment for a once-progressive and fatal disease, caveats to management in certain IPF subgroups and the expansion of indications to include other non-IPF progressive fibrotic lung disease highlight the current state of the available anti-fibrotics.
ILD Day: Recent updates in treatment, management of interstitial lung ...
Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases. There are more than 200 causes of ILD.
Update in Interstitial Lung Disease 2020 | American Journal of ...
IPF is a progressive and fatal lung disease with increasing prevalence and a median survival of 3–5 years after diagnosis. IPF is characterized by altered cellular composition and dysfunction of resident and immune cells in the lung, leading to excessive accumulation of extracellular matrix (ECM) and progressive scarring.
Interstitial lung disease - News and Latest Updates - Medical Xpress
Oct 14, 2024 · Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs...
Interstitial lung disease 2021 - The Lancet
Sep 6, 2021 · Interstitial lung diseases (ILDs) are a heterogeneous group of diffuse parenchymal lung disorders of known or unknown cause, with varying degrees of inflammation or fibrosis.
Interstitial Lung Disease News, Research - News-Medical.net
Oct 14, 2024 · Interstitial Lung Disease (ILD), a condition characterised by inflammation and fibrosis, is a major cause of severe respiratory illness and can occur in children.
Interstitial Lung Disease - latest research news and features
News on interstitial lung disease. Diseases, Conditions, Syndromes. Experts update recommendations for modern approach for systemic sclerosis. Systemic sclerosis (SSc) is a rare connective...
Interstitial lung disease - Symptoms and causes - Mayo Clinic
Apr 25, 2023 · Interstitial (in-tur-STISH-ul) lung disease describes a large group of disorders, most of which cause progressive scarring of lung tissue. The scarring associated with interstitial lung disease eventually affects your ability to breathe and get enough oxygen into your bloodstream.